BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 20600306)

  • 21. Implementing KDOQI CKD definition and staging guidelines in Southern California Kaiser Permanente.
    Rutkowski M; Mann W; Derose S; Selevan D; Pascual N; Diesto J; Crooks P
    Am J Kidney Dis; 2009 Mar; 53(3 Suppl 3):S86-99. PubMed ID: 19231766
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Progression of renal disease: current concepts and therapeutic approaches.
    Bourgoignie JJ
    Kidney Int Suppl; 1992 May; 36():S61-5. PubMed ID: 1614070
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of obesity and its bioclinical correlates in the progression of chronic kidney disease.
    Chalmers L; Kaskel FJ; Bamgbola O
    Adv Chronic Kidney Dis; 2006 Oct; 13(4):352-64. PubMed ID: 17045221
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chronic kidney disease and the risk for cardiovascular disease, renal replacement, and death in the United States Medicare population, 1998 to 1999.
    Foley RN; Murray AM; Li S; Herzog CA; McBean AM; Eggers PW; Collins AJ
    J Am Soc Nephrol; 2005 Feb; 16(2):489-95. PubMed ID: 15590763
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Progression in chronic kidney disease.
    Eddy AA
    Adv Chronic Kidney Dis; 2005 Oct; 12(4):353-65. PubMed ID: 16198274
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Progressive renal failure. Why blood pressure must now be monitored].
    Tepel M; van der Giet M; Zidek W
    MMW Fortschr Med; 2000 Jun; 142(25):42-4. PubMed ID: 10920669
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Non-immunological therapy in nephropathies leading to chronic renal failure and in post-transplant chronic renal dysfunction].
    Amore A; Camilla R; Rollino C; Avenatti E; Campolo F; Peruzzi L; Conti G; Coppo R
    G Ital Nefrol; 2008; 25 Suppl 44():53-63. PubMed ID: 19048587
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The management in chronic kidney disease (CKD)].
    Busuioc M; Gusbeth-Tatomir P; Covic A
    Rev Med Chir Soc Med Nat Iasi; 2008; 112(4):896-901. PubMed ID: 20209759
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Hepatitis C virus and chronic progressive kidney disease].
    Kes P; Slavicek J
    Acta Med Croatica; 2009 Dec; 63(5):431-6. PubMed ID: 20198903
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Managing chronic kidney disease in diabetes patients with the latest chemical therapies.
    Hu J; Du Y
    Expert Rev Clin Pharmacol; 2019 Jan; 12(1):53-60. PubMed ID: 30509118
    [No Abstract]   [Full Text] [Related]  

  • 31. [Electrolyte and acid-base balance disorders in advanced chronic kidney disease].
    Alcázar Arroyo R
    Nefrologia; 2008; 28 Suppl 3():87-93. PubMed ID: 19018744
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Calcium channel blockers and nephroprotection.
    Ungar A; Di Serio C; Lambertucci L; Monami M; Masotti G
    Aging Clin Exp Res; 2005 Aug; 17(4 Suppl):31-9. PubMed ID: 16640171
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The global burden of chronic kidney disease and the way forward.
    Alebiosu CO; Ayodele OE
    Ethn Dis; 2005; 15(3):418-23. PubMed ID: 16108301
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Calcium channel blockers versus angiotensin-converting enzyme inhibitors: renal effects.
    Linas S
    Am J Kidney Dis; 1990 Oct; 16(4 Suppl 1):15-9. PubMed ID: 2220796
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Management of anemia in patients with chronic kidney disease.
    Wish JB
    Postgrad Med; 2004 Nov; 116(5 Suppl Anemia):23-9. PubMed ID: 19667681
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chronic kidney disease as an independent risk factor for new-onset atrial fibrillation in hypertensive patients.
    Horio T; Iwashima Y; Kamide K; Tokudome T; Yoshihara F; Nakamura S; Kawano Y
    J Hypertens; 2010 Aug; 28(8):1738-44. PubMed ID: 20485194
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Strategies to retard the progression of chronic kidney disease.
    Zandi-Nejad K; Brenner BM
    Med Clin North Am; 2005 May; 89(3):489-509. PubMed ID: 15755464
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Current drug development challenges in chronic kidney disease (CKD)--identification of individualized determinants of renal progression and premature cardiovascular disease (CVD).
    Formentini I; Bobadilla M; Haefliger C; Hartmann G; Loghman-Adham M; Mizrahi J; Pomposiello S; Prunotto M; Meier M
    Nephrol Dial Transplant; 2012 Oct; 27 Suppl 3():iii81-8. PubMed ID: 22734108
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chronic kidney disease and diabetes.
    Pyram R; Kansara A; Banerji MA; Loney-Hutchinson L
    Maturitas; 2012 Feb; 71(2):94-103. PubMed ID: 22137331
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A quantitative approach to drug dosing in chronic kidney disease.
    Olyaei AJ; Steffl JL
    Blood Purif; 2011; 31(1-3):138-45. PubMed ID: 21228582
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.